vs
MERCANTILE BANK CORP（MBWM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是MERCANTILE BANK CORP的1.1倍（$75.5M vs $67.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.1%）
泰米尔纳德商业银行（TMB）是一家印度银行，总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年，最初名为纳达尔银行，1962年11月更名为泰米尔纳德商业银行，以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MBWM vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$67.6M
两年增速更快
PBYI
近两年复合增速
9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.6M | $75.5M |
| 净利润 | $22.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 33.6% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 16.1% | — |
| 每股收益（稀释后） | $1.32 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MBWMPBYI
| Q1 26 | $67.6M | — | ||
| Q4 25 | $62.1M | $75.5M | ||
| Q3 25 | $62.4M | $54.5M | ||
| Q2 25 | $60.9M | $52.4M | ||
| Q1 25 | $57.3M | $46.0M | ||
| Q4 24 | $58.5M | $59.1M | ||
| Q3 24 | $58.0M | $80.5M | ||
| Q2 24 | $56.8M | $47.1M |
净利润MBWMPBYI
| Q1 26 | $22.7M | — | ||
| Q4 25 | $22.8M | — | ||
| Q3 25 | $23.8M | $8.8M | ||
| Q2 25 | $22.6M | $5.9M | ||
| Q1 25 | $19.5M | $3.0M | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $19.6M | $20.3M | ||
| Q2 24 | $18.8M | $-4.5M |
毛利率MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | 42.0% | 22.7% | ||
| Q3 25 | 44.0% | 17.6% | ||
| Q2 25 | 42.6% | 12.7% | ||
| Q1 25 | 42.0% | 8.7% | ||
| Q4 24 | 39.7% | 22.6% | ||
| Q3 24 | 42.4% | 27.4% | ||
| Q2 24 | 41.4% | -4.6% |
净利率MBWMPBYI
| Q1 26 | 33.6% | — | ||
| Q4 25 | 36.8% | — | ||
| Q3 25 | 38.1% | 16.2% | ||
| Q2 25 | 37.1% | 11.2% | ||
| Q1 25 | 34.1% | 6.5% | ||
| Q4 24 | 33.5% | — | ||
| Q3 24 | 33.8% | 25.2% | ||
| Q2 24 | 33.1% | -9.6% |
每股收益（稀释后）MBWMPBYI
| Q1 26 | $1.32 | — | ||
| Q4 25 | $1.41 | $0.26 | ||
| Q3 25 | $1.46 | $0.17 | ||
| Q2 25 | $1.39 | $0.12 | ||
| Q1 25 | $1.21 | $0.06 | ||
| Q4 24 | $1.20 | $0.40 | ||
| Q3 24 | $1.22 | $0.41 | ||
| Q2 24 | $1.17 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $1.5M | $22.7M |
| 股东权益账面价值 | $736.9M | $130.3M |
| 总资产 | $6.9B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务MBWMPBYI
| Q1 26 | $1.5M | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益MBWMPBYI
| Q1 26 | $736.9M | — | ||
| Q4 25 | $724.9M | $130.3M | ||
| Q3 25 | $657.6M | $115.3M | ||
| Q2 25 | $631.5M | $104.7M | ||
| Q1 25 | $608.3M | $97.1M | ||
| Q4 24 | $584.5M | $92.1M | ||
| Q3 24 | $583.3M | $71.1M | ||
| Q2 24 | $551.2M | $48.5M |
总资产MBWMPBYI
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.8B | $216.3M | ||
| Q3 25 | $6.3B | $202.9M | ||
| Q2 25 | $6.2B | $194.9M | ||
| Q1 25 | $6.1B | $196.2M | ||
| Q4 24 | $6.1B | $213.3M | ||
| Q3 24 | $5.9B | $220.7M | ||
| Q2 24 | $5.6B | $205.0M |
负债/权益比MBWMPBYI
| Q1 26 | 0.00× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | $18.0M | $14.4M | ||
| Q3 25 | $23.1M | $9.7M | ||
| Q2 25 | $-7.8M | $14.1M | ||
| Q1 25 | $-3.0M | $3.6M | ||
| Q4 24 | $101.1M | $15.6M | ||
| Q3 24 | $-8.1M | $11.0M | ||
| Q2 24 | $9.1M | $1.0M |
自由现金流MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率MBWMPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.79× | — | ||
| Q3 25 | 0.97× | 1.10× | ||
| Q2 25 | -0.35× | 2.41× | ||
| Q1 25 | -0.15× | 1.21× | ||
| Q4 24 | 5.15× | — | ||
| Q3 24 | -0.41× | 0.54× | ||
| Q2 24 | 0.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
PBYI
暂无分部数据
